IT1291892B1
(it)
*
|
1997-04-24 |
1999-01-21 |
Alessandro Lambiase |
Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella
|
ES2206965T3
(es)
|
1997-07-29 |
2004-05-16 |
Alcon Laboratories, Inc. |
Composiciones oftalmicas que contienen polimeros de galactomanana y borato.
|
IT1305294B1
(it)
|
1999-01-29 |
2001-05-04 |
Alessandro Lambiase |
Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
|
US6281192B1
(en)
|
1999-03-01 |
2001-08-28 |
Vista Scientific Llc |
Mucin containing ophthalmic preparations
|
US6878694B2
(en)
|
2000-12-20 |
2005-04-12 |
Alcon, Inc. |
Ophthalmic irrigating solution adapted for use in lasik surgery
|
WO2002049611A2
(en)
*
|
2000-12-20 |
2002-06-27 |
Alcon, Inc. |
Ophthalmic lubricating solution adapted for use in lasik surgery
|
CA2441352C
(en)
*
|
2001-02-15 |
2010-05-25 |
Access Pharmaceuticals, Inc. |
Liquid formulations for the prevention and treatment of mucosal diseases and disorders
|
US7544348B2
(en)
*
|
2001-02-15 |
2009-06-09 |
Access Pharmaceuticals, Inc. |
Liquid formulations for the prevention and treatment of mucosal diseases and disorders
|
US6465506B2
(en)
*
|
2001-02-22 |
2002-10-15 |
Ophthalmic Research Associates, Inc. |
Instillation techniques for ophthalmic agents to enhance treatment effect
|
CA2447383A1
(en)
*
|
2001-06-29 |
2003-01-09 |
Biovitrum Ab |
Process for bulk autoclaving
|
CA2456833A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Masahiro Inohara |
Polysaccharide-containing compositions and use thereof
|
US20040214754A1
(en)
*
|
2001-10-03 |
2004-10-28 |
Ellis Edward J. |
Ophthalmic preparation containing glycomacropeptide
|
US20040220089A1
(en)
*
|
2001-10-03 |
2004-11-04 |
Ellis Edward J. |
Ophthalmic preparation containing glycoprotein
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
EP2316459B1
(de)
|
2002-07-29 |
2013-11-06 |
Rigel Pharmaceuticals, Inc. |
2,4-Pyrimidindiaminen zur Behandlung oder Vorbeugung von Autoimmunerkrankungen
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
DK1663242T3
(da)
|
2003-08-07 |
2011-08-01 |
Rigel Pharmaceuticals Inc |
2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
|
EP2113246B1
(de)
*
|
2003-08-07 |
2016-06-22 |
Allergan, Inc. |
Zusammensetzungen zur Abgabe von Therapeutika in die Augen und Verfahren zu ihrer Herstellung und Verwendung
|
WO2005039640A1
(en)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
|
WO2005046728A1
(ja)
*
|
2003-11-10 |
2005-05-26 |
Toray Industries, Inc. |
多糖類含有組成物および涙液層安定化点眼剤
|
US20050210732A1
(en)
*
|
2004-03-26 |
2005-09-29 |
Guerin John W |
Crank bait tail
|
JP4395016B2
(ja)
*
|
2004-06-29 |
2010-01-06 |
日清オイリオグループ株式会社 |
ゲル状吸水用組成物
|
US7726809B2
(en)
*
|
2005-02-09 |
2010-06-01 |
Safilens S.R.L. |
Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
|
ES2522895T3
(es)
|
2005-03-03 |
2014-11-19 |
Alfa Wassermann S.P.A. |
Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
|
ITBO20050388A1
(it)
*
|
2005-06-06 |
2006-12-07 |
Alfa Wassermann Spa |
Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
|
ITRM20050447A1
(it)
*
|
2005-08-19 |
2007-02-20 |
Anabasis S R L |
Uso del nerve growth factor in collirio nella terapia di patologie del sistema nervoso centrale, quali la malattia di alzheimer e il morbo di parkinson.
|
EP1991532B1
(de)
|
2006-02-24 |
2017-01-11 |
Rigel Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur hemmung des jak-pfades
|
JP5134778B2
(ja)
*
|
2006-03-10 |
2013-01-30 |
日清オイリオグループ株式会社 |
ゲル組成物及び該ゲル組成物を使用したパック化粧料
|
ES2380551T3
(es)
|
2006-11-21 |
2012-05-16 |
Rigel Pharmaceuticals, Inc. |
Sales de profármaco de compuestos de 2,4-pirimidindiamina y sus usos
|
ITRM20070510A1
(it)
*
|
2007-10-02 |
2009-04-03 |
Rmfa Trading S A |
Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
|
GB0719969D0
(en)
|
2007-10-12 |
2007-11-21 |
Cambridge Entpr Ltd |
Substance monitoring and control in human or animal bodies
|
CA2708281A1
(en)
|
2007-12-11 |
2009-08-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
US7842714B2
(en)
*
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
JP5815411B2
(ja)
|
2008-12-30 |
2015-11-17 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
ピリミジンジアミンキナーゼ阻害剤
|
PE20110924A1
(es)
|
2009-01-23 |
2011-12-24 |
Rigel Pharmaceuticals Inc |
Derivados de 2, 4-diamino-pirimidina n2, n4-disustituidos como inhibidores de jak3
|
CN102405044A
(zh)
|
2009-02-06 |
2012-04-04 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
JP5738292B2
(ja)
|
2009-07-28 |
2015-06-24 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jak経路の阻害のための組成物および方法
|
IT1396607B1
(it)
*
|
2009-11-16 |
2012-12-14 |
Hmfra Hungary Ltd Liability Company |
Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
|
IT1397132B1
(it)
|
2009-12-01 |
2013-01-04 |
Alfa Wassermann Spa |
Composizioni comprendenti antiinfiammatori non steroidei.
|
BR112012022209A2
(pt)
|
2010-03-03 |
2017-06-06 |
Neonc Tech Inc |
composições farmacêuticas compreendendo monoterpenos
|
AU2011242562B2
(en)
|
2010-04-24 |
2016-10-13 |
Mycovia Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
DK2575973T3
(en)
|
2010-05-24 |
2017-08-14 |
Indena Spa |
TAMARED SEED POLYSACCHARIDE AND FERULA HERMONIS EXTRACT USED IN TREATMENT OF INFLAMMATORY DISEASES
|
PT2575971E
(pt)
|
2010-05-24 |
2016-03-04 |
Indena Spa |
Extratos combinados de plantas para utilização no tratamento de infeções microbianas
|
JP5620168B2
(ja)
*
|
2010-06-30 |
2014-11-05 |
Dsp五協フード&ケミカル株式会社 |
キシログルカン−カチオン複合体及びそれを含有する安定化組成物
|
ES2560954T3
(es)
*
|
2010-07-12 |
2016-02-23 |
Zambon S.P.A. |
Polímero polisacárido de las semillas del árbol tamarindo para la utilización en el tratamiento de la tos seca
|
JP6073221B2
(ja)
|
2010-07-28 |
2017-02-01 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jak経路の阻害のための組成物および方法
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
ES2610425T3
(es)
|
2010-08-27 |
2017-04-27 |
Neonc Technologies Inc. |
Composiciones farmacéuticas que comprenden carbamatos de alcohol perilílico
|
EP2632903A4
(de)
|
2010-10-28 |
2014-11-26 |
Viamet Pharmaceuticals Inc |
Metalloenzymhemmerverbindungen
|
EP3483147A1
(de)
|
2010-11-13 |
2019-05-15 |
Innocrin Pharmaceuticals, Inc. |
Metalloenzyminhibitorverbindungen
|
CN105616391B
(zh)
|
2010-12-17 |
2021-03-19 |
尼昂克技术公司 |
使用异紫苏醇的方法和装置
|
WO2012116254A2
(en)
|
2011-02-25 |
2012-08-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chrysophaentin analogs that inhibit ftsz protein
|
ITMI20110583A1
(it)
|
2011-04-08 |
2012-10-09 |
Hmfra Hungary Ltd Liability Company |
Preparazioni oftalmiche a base di pacap (pituitary adenylate cyclase activating polypeptide) al fine di ripristinare la normale funzione visiva nel glaucoma in fase precoce
|
RU2463022C1
(ru)
*
|
2011-04-19 |
2012-10-10 |
Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" |
Способ лечения больных с синдромом "сухого глаза"
|
WO2012149416A2
(en)
|
2011-04-28 |
2012-11-01 |
University Of Southern California |
Human myeloid derived suppressor cell cancer markers
|
EA024385B1
(ru)
|
2011-06-19 |
2016-09-30 |
Ваймет Фармасьютикалс, Инк. |
Соединения, ингибирующие металлоферменты
|
KR101912844B1
(ko)
|
2011-06-19 |
2018-10-30 |
비아멧 파마슈티컬즈(엔씨), 인코포레이티드 |
금속효소 억제제 화합물
|
KR101964195B1
(ko)
|
2011-06-23 |
2019-04-01 |
비아멧 파마슈티컬즈(엔씨), 인코포레이티드 |
금속효소 억제제 화합물
|
BR112014002934A2
(pt)
*
|
2011-08-12 |
2017-04-04 |
Zambon Spa |
uso de um polímero de polissacarídeo obtido a partir das sementes da arvoré de tamarindo, e, preparação na forma de uma dosagem líquida para aplicação tópica
|
JP6376550B2
(ja)
*
|
2011-09-07 |
2018-08-22 |
千寿製薬株式会社 |
水性液剤の粘度低下抑制方法
|
WO2013046059A2
(en)
*
|
2011-09-27 |
2013-04-04 |
Sykora Robert C |
Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
|
LT2788343T
(lt)
|
2011-12-11 |
2018-06-11 |
Viamet Pharmaceuticals (NC), Inc. |
Metalo fermentus slopinantys junginiai
|
KR102061137B1
(ko)
|
2012-01-20 |
2019-12-31 |
마이코비아 파마슈티컬즈, 인코포레이티드 |
금속효소 억제제 화합물
|
EP2828241B1
(de)
|
2012-03-23 |
2018-09-12 |
Mateon Therapeutics, Inc. |
Zusammensetzungen und verfahren zur hemmung von cathepsinen
|
WO2013173506A2
(en)
|
2012-05-16 |
2013-11-21 |
Rigel Pharmaceuticals, Inc. |
Method of treating muscular degradation
|
EP3016634A2
(de)
*
|
2013-07-05 |
2016-05-11 |
Therakine Biodelivery GmbH |
Wirkstofffreisetzungszusammensetzung zur topischen anwendung und injektionen und ophthalmische formulierungen, verfahren zur herstellung davon und verfahren zur freisetzung einer wirkstofffreisetzungszusammensetzung
|
EP2883931A1
(de)
*
|
2013-12-12 |
2015-06-17 |
Omya International AG |
Verbesserte Gelstabilität
|
CA2945631C
(en)
|
2014-04-15 |
2023-04-11 |
Novintethical Pharma Sa |
Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
|
US11623008B2
(en)
*
|
2014-08-20 |
2023-04-11 |
Professional Compounding Centers Of America |
Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
|
WO2016130800A2
(en)
|
2015-02-12 |
2016-08-18 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
EP3103438B1
(de)
|
2015-06-11 |
2018-11-14 |
Novintethical Pharma SA |
Topische nasale zusammensetzungen mit xyloglucanen zur verwendung als abschwellendes mittel
|
KR20180026487A
(ko)
*
|
2015-07-13 |
2018-03-12 |
가부시키가이샤 토호쿠 테크노 아치 |
시신경 보호용 조성물
|
CA2993661A1
(en)
|
2015-08-04 |
2017-02-09 |
Rigel Pharmaceuticals, Inc. |
Benzazole compounds and methods for making and using the compounds
|
ES2877566T3
(es)
*
|
2015-08-07 |
2021-11-17 |
Council Scient Ind Res |
Una formulación de lubricante de carbamoiletil katira y un proceso para la preparación de la misma
|
EP3397629B1
(de)
|
2015-12-30 |
2023-04-19 |
NQP 1598, Ltd. |
Metalloenzyminhibitorverbindungen
|
EP3475263B1
(de)
|
2016-06-27 |
2022-12-28 |
Rigel Pharmaceuticals, Inc. |
2,4-diamino-pyrimidinverbindungen und dessen verwendung als irak4 hemmer
|
EP3532465B1
(de)
|
2016-10-26 |
2023-03-01 |
Rigel Pharmaceuticals, Inc. |
Pyrazolamidverbindungen als irak-inhibitoren
|
CN110099899B
(zh)
|
2016-10-26 |
2024-01-02 |
里格尔药品股份有限公司 |
用作irak抑制剂的噁唑衍生物及其制备方法
|
JP7144411B2
(ja)
|
2016-11-30 |
2022-09-29 |
ネオンク テクノロジーズ インク. |
ペリリルアルコール-3-ブロモピルベート複合体及びがんの治療方法
|
RU2764666C2
(ru)
|
2016-12-29 |
2022-01-19 |
Селенити Терапьютикс (Бермуда), Лтд. |
Соединения, ингибирующие металлоферменты
|
WO2018125799A2
(en)
|
2016-12-29 |
2018-07-05 |
Viamet Pharmaceuticals (Bermuda), Ltd. |
Metalloenzyme inhibitor compounds
|
JP7167069B2
(ja)
|
2017-06-29 |
2022-11-08 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
キナーゼ阻害剤ならびに作製および使用のための方法
|
US11129862B2
(en)
*
|
2017-08-30 |
2021-09-28 |
Johnson & Johnson Consumer Inc. |
Ophthalmic compositions
|
US20210292410A1
(en)
|
2017-12-07 |
2021-09-23 |
Morphosys Ag |
Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment
|
JP7325425B2
(ja)
|
2018-02-08 |
2023-08-14 |
ネオンク テクノロジーズ インク. |
血液脳関門を透過性にする方法
|
DK3788045T3
(da)
|
2018-05-03 |
2023-06-26 |
Rigel Pharmaceuticals Inc |
RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse deraf
|
US10815206B2
(en)
|
2018-05-03 |
2020-10-27 |
Rigel Pharmaceuticals, Inc. |
RIP1 inhibitory compounds and methods for making and using the same
|
WO2020092845A1
(en)
|
2018-11-01 |
2020-05-07 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
US20200377518A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
CA3147443A1
(en)
|
2019-08-08 |
2021-02-11 |
Rigel Pharmaceuticals, Inc. |
Compounds and method for treating cytokine release syndrome
|
ES2970382T3
(es)
|
2019-08-14 |
2024-05-28 |
Rigel Pharmaceuticals Inc |
Método para bloquear o mejorar el síndrome de liberación de citocinas
|
WO2021041898A1
(en)
|
2019-08-30 |
2021-03-04 |
Rigel Pharmaceuticals, Inc. |
Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations
|
JP7443495B2
(ja)
|
2019-09-06 |
2024-03-05 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
ヘテロ環式rip1キナーゼ阻害剤
|
JOP20220056A1
(ar)
|
2019-09-06 |
2023-01-30 |
Rigel Pharmaceuticals Inc |
مركبات rip1 تثبيطية وطرق عملها واستخدامها
|
IL292536A
(en)
|
2019-11-07 |
2022-06-01 |
Rigel Pharmaceuticals Inc |
Heterocyclic compounds inhibit rip1
|
WO2022187303A1
(en)
|
2021-03-03 |
2022-09-09 |
Rigel Pharmaceuticals, Inc. |
A method for treating a disease or condition using a pyrazole compound or formulation thereof
|
TW202300490A
(zh)
|
2021-03-11 |
2023-01-01 |
美商雷傑製藥公司 |
雜環rip1激酶抑制劑
|
TW202346291A
(zh)
|
2022-03-23 |
2023-12-01 |
美商雷傑製藥公司 |
作為irak抑制劑的嘧啶—2—基—吡唑化合物
|
US20230312568A1
(en)
|
2022-03-31 |
2023-10-05 |
Rigel Pharmaceuticals, Inc. |
Tricyclic irak inhibitors
|